Mas texto en la ventana.
82% of participants at Biospain identified real business opportunities
Attendance reached a total of 855 public and private entities, an increase of 12.2% compared to 2012, nearly 34% of them non-Spanish, compared to 28% at the last edition.
Madrid, 29 October 2014. The 7th International Biotechnology Conference, BioSpain 2014 (www.biospain2014.org), the main biotechnology event held in Spain and one of the biggest in the world, took place between the 24th and the 26th of September at the Palacio de Congresos y Exposiciones de Galicia, in Santiago de Compostela (A Corunna). The biennial event, which was organised by the Spanish Bioindustry Association (ASEBIO) – and on this edition also by the Autonomous Government of Galicia, the University of Santiago de Compostela, the University of Vigo and Santiago City Council – once more bolstered its international character: from the 855 private and public institutions attending the fair (an increase of 12.2% compared to the previous edition), 289 were non-Spanish and represented a total of 37 countries, 34% of this year's total, compared to 28% at the last edition, increasing its internationalisation by 37.6% compared to 2012.
66% of companies came from Spain, followed by the United Kingdom (6.21%), France (3.51%), Portugal (3.40%), the United States (2.93%), Colombia (2.34%), Mexico (2.34%), Switzerland (1.87%), among others.
In addition, this 7th edition of Biospain, which coincided with the Year of Biotechnology in Spain and the 15th anniversary of ASEBIO, counted with the presence of 200 exhibitors and 50 investors - 80% of them non-Spanish - including venture capital funds, big pharma investment funds, business angels and others, all of whom participated in the Investment Forum, where the business plans of 40 companies from a variety of countries were studied. The partnering event hosted 3,327 business meetings - an increase of 20% compared to the previous edition - with a total of 2,000 participants (8% more), consolidating Biospain 2014 as the fifth biggest industry event globally in terms of the number of business development meetings.
During Biospain 2014 a total of 50 parallel and scientific conferences took place, as well as 37 company presentations, with 720 products available for licensing presented at the partnering.
The Biospain Organisational Committee conducted a satisfaction survey to which 25% of participants responded. According to the results of the survey, completed primarily by representatives of biotechnology businesses and research institutions, Biospain met the expectations of 55% of respondents and exceeded the expectations of 37%. 82% of respondents identified real business opportunities and, regarding their general assessment of the event, 54% stated that it was good, 19% stated that it was really good, and 24% found it average, resulting in 97% of participants satisfied.
Here are some of the participants' reviews:
-‘BioSpain is a unique event where venture capital funds, big pharma investment funds, and creative entrepreneurs from all around the world can exchange ideas in a relaxed atmosphere, as well as enjoy the Spanish culture. In my opinion, there is no partnering event like it.’(Joe Fernández, angel investor, Active Motif CEO and Invitrogen founder, United States).
-‘Biospain really attained the objectives sought: learning about the European market, creating contacts interested in the region and, thus, eager to discover the possibilities that our country offers’. (Cecilia Pérez, Sectorial Coordinator of Uruguay XXI, Uruguay)
-‘BioSpain 2014 has experienced a large increase in the number of participants compared to previous editions, combining high quality in the partnering with interesting presentations in relevant areas of life sciences’. (Marcel Kloosterman, Senior Investment Manager, DSM Venturing & Chemelot Ventures, Netherlands).
-‘In my first visit to Biospain, I was impressed by the number of diverse sessions, the large number of start-ups that presented sophisticated developments in creative partnering meetings, and an attractive commercial fair with more companies than I expected’. (Gabriela Couto, Director of Business Development at BioTD, Costa Rica).
-‘I had the opportunity to live one of the most valuable experiences in my professional career. I attained my goals, focused on gaining a better understanding of the dynamics of support and international innovative solutions in the research of the biotechnology industry for animal health.’ (Patricia Acuña, Research & Development Project Leader - Santa Elena Virbac, Uruguay)
-‘Once again, Biospain 2014 proved that it is one of the world’s most attractive biopartnering events, with important professionals from all the different biotechnology niches. It was perfectly organised, with an exceptional scientific and business programme. I have already pencilled-in the next edition in 2016 in my agenda.’ (Oliver Schnell, Head of Marketing in BIOCOM AG, editor of European Biotechnology News, Germany).
Ana Mato, Minister for Health, Social Services and Equality, accompanied by Alberto Nuñez Feijoó, President of Galicia, and around 20 Regional Ministers for Health, Economy, Environment and Agriculture from all around Spain as well as Simon Manley, the UK Ambassador in Spain and other officials, visited the commercial fair at Biospain 2014. The Minister for Health and her Regional counter-parts also participated in an informal inter-regional meeting to consider issues including health innovation policies, one of the topics on the event programme.
Among the noteworthy new features at this fair was the Biolatam Showcase - an exclusive space for Latin American biotechnology - in which countries such as Peru, Argentina, Mexico, Colombia, Costa Rica, Brasil, Chile and Uruguay were present; the Xacobio, which took place between the 21st and the 23rd of September and during which 25 participants from 17 countries shared an unforgettable experience while walking the Camino de Santiago; and the second edition of the Training and Employment Forum, which this year was organised in collaboration with FEBiotec, with 297 job seekers and 20 institutions registered - and 71 meetings having taken place.
BioSpain 2014 has also, for the first time, integrated the 'Open Innovation' model which is currently being adopted throughout all business sectors. Con-sequently, the fair has ceded control over some of its content to high profile partners: ‘We have opened the conference to 10 scientific societies which have helped to enrich our programme and we have also hosted the ‘Stakeholder Forum’, through which, also for the first time, we have opened our doors to a non-professional public in order to discuss experiences with patients, consumers, farmers and environmentalists’, explained Jorge Barrero, Director of Biospain 2014.
The official sponsors for BioSpain 2014 are Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).
Head of Communications for BioSpain 2014 and ASEBIO
Landline: + 34 912109374/10
Mobile: + 34 663 117 293
BioSpain 2014 Press Office: BERBÉS ASOCIADOS
María González / Jorge Sánchez / Irene Fernández
Landline/mobile: 91 563 23 00 / 677 456 806 / 678 544 149 / 661 67 82 83
Twitter: @BioSpain2014 (https://twitter.com/BioSpain2014)
Linkedin Group: ‘BioSpain 2014’
Inversores de 11 países analizan 30 proyectos de biotecnología españolaRead more
El top ten de fondos de inversión asistentes a Biospain 2016 gestionan activos valorados en más de 5.000 millones de eurosRead more
The ten biggest funds at Biospain 2016 manage assets of over 5 billion eurosRead more
Los pacientes piden en Biospain 2016 una participación activa en las políticas de salud y en el sistema sanitarioRead more
El descubrimiento del ‘GPS humano’ abre una nueva era en la ingeniería genéticaRead more
La biotecnología agrícola, clave para afrontar el problema de la superpoblación y el cambio climáticoRead more
Biospain 2016 ya cuenta con una APP gratuita para seguir el eventoRead more
US expects to increase its presence in Biospain 2016Read more
Bilbao will host BioSpain 2016Read more
BioSpain 2016 will be the hub of Biotechnology in AutummRead more
Bilbao acogerá BioSpain 2016Read more
EE.UU. prevé incrementar su presencia en Biospain 2016Read more
BioSpain 2016 selecciona a cuatro sociedades científicasRead more
El 82% de los asistentes a Biospain identificaron oportunidades reales de negocioRead more
La inmunoterapia se postula como uno de los pilares terapéuticos del cáncerRead more
La bioeconomía se consolida como una herramienta clave para afrontar los retos futuros del planetaRead more
BioSpain 2014 increases its internationalisation by 43% compared to the previous editionRead more
Participantes en Biospain de 16 países llegarán a la feria por el camino #XacobioRead more
BioSpain 2014 amplía su Foro de Inversión con más perfiles de inversores y más empresas participantesRead more
BioSpain 2014 expands its Investment Forum through wider range of investor profiles and more participating companiesRead more
BioSpain 2014 refuerza su presencia internacional e incorpora el modelo de “Innovación en abierto”Read more
BioSpain 2014 strengthens its international presence and includes ‘Open Innovation’ modelRead more